Antioxidant supplement cost saving and effective for degenerative eye disease

August 24, 2017
Credit: CC0 Public Domain

A supplement that combines antioxidants with zinc and copper is a relatively inexpensive and effective means of halting the progression of a certain type of degenerative eye disease, concludes research published online in the British Journal of Ophthalmology.

Given the costs and side effects of the current range of drugs used to treat the 'wet' form of age related macular degeneration (nAMD), the NHS should fund this treatment in people who already have the condition in one eye, say the researchers.

In 'wet' AMD, grow underneath the retina. These vessels can leak fluid and blood, which can damage the macula—the part of the retina responsible for central vision.

But the drugs (anti-VEGF therapies) currently used to 'wet' AMD are expensive and have been linked to heightened risk of inflammation of the inside of the eye (endophthalmitis) and possibly stroke as well.

The researchers base their findings on data from the Age Related Eye Disease Study (AREDS) as well as UK treatment costs and AMD prevalence figures for people over the age of 55.

AREDS concluded that a daily supplement combining high dose antioxidants and zinc lowered the risk of developing 'wet' AMD after assessing the effectiveness of two types of supplement for treating people with early stage disease in one (category 4) or both (category 3) eyes.

Formulation 1 contained high doses of vitamins C and E, beta carotene, zinc and copper; in formulation 2, was replaced with lutein and zeaxanthin, but the other constituents remained the same. Both formulations are commercially available.

The researchers applied a statistical approach (Markov Model) to all the data to predict outcomes in those given one or other compared with those not given them.

Their analysis showed that both formulations are cost effective for treating patients with early stage 'wet' AMD, but they were more cost effective for those with the condition in just one eye.

Over the course of a lifetime, the researchers calculated that these patients would need nearly eight fewer injections of anti-VEGF therapies into their eye. This represents a cost saving to the NHS of nearly £3000 per patient, adding up to around £131 million a year.

And these patients would gain additional time lived without impaired vision, known as QALYs (10.59 compared with 10.43 for those not given the supplements).

"Given the burden and cost of treatment, prevention of nAMD seems, therefore, an attractive strategy to avoid the chronic and costly anti-VEG therapies and preserve visual function," write the researchers.

The beneficial costs and outcomes do assume that people with wet AMD in one eye would be highly motivated to keep on taking the supplements to stave off vision loss in the second eye, acknowledge the researchers.

While there would still be savings to be made by giving supplements to people with intermediate stage wet AMD in both eyes, the argument for funding them for people with the condition in one eye is extremely strong, they say.

"AREDS supplements are a dominant cost-effective intervention for category 4 AREDS patients, as they are both less expensive than standard care and more effective, and therefore should be considered for public funding," they conclude.

Explore further: Study provides clarity on supplements for protection against blinding eye disease

More information: Aaron Y Lee et al. Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data, British Journal of Ophthalmology (2017). DOI: 10.1136/bjophthalmol-2017-310939

Related Stories

Study provides clarity on supplements for protection against blinding eye disease

May 6, 2013
Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans, according to ...

Long-term daily multivitamin supplement use decreases cataract risk in men

February 20, 2014
Long-term daily multivitamin supplement use may lower cataract risk in men, according to a study of nearly 15,000 male physicians published this month in Ophthalmology, the journal of the American Academy of Ophthalmology.

Top-selling eye vitamins found not to match scientific evidence

December 9, 2014
With Americans spending billions of dollars each year on nutritional supplements, researchers have analyzed popular eye vitamins to determine whether their formulations and claims are consistent with scientific findings. ...

Is more, better? Finding the balance between nutritional supplements and eye health

October 27, 2016
In the past decade, ophthalmologists have been prescribing nutritional supplements to be taken daily to prevent or slow vision loss from age-related macular degeneration (AMD). Now, using nutritional supplements for eye health ...

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Recommended for you

Coming soon: Glaucoma self-care, from home?

September 23, 2017
(HealthDay)—For many glaucoma patients, repeat trips to a doctor's office to check on their eyes can be a real pain.

Researchers identify potential biomarkers of age-related macular degeneration

September 12, 2017
Patients with any stage of age-related macular degeneration (AMD) carry signs of the disease in their blood that may be found through special laboratory tests, according to a new study led by AMD researchers based at Massachusetts ...

Researchers unlock regenerative potential of cells in the mouse retina

August 28, 2017
Cells within an injured mouse eye can be coaxed into regenerating neurons and those new neurons appear to integrate themselves into the eye's circuitry, new research shows. The findings potentially open the door to new treatments ...

Antioxidant supplement cost saving and effective for degenerative eye disease

August 24, 2017
A supplement that combines antioxidants with zinc and copper is a relatively inexpensive and effective means of halting the progression of a certain type of degenerative eye disease, concludes research published online in ...

Researchers identify key compounds to resolve abnormal vascular growth in AMD

August 21, 2017
A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical model, according to a new study led by Massachusetts Eye and Ear researchers. ...

World's blind population to soar: study

August 3, 2017
The world's blind will increase threefold from about 36 million today to 115 million in 2050 as populations expand and individuals grow ever older, researchers said Thursday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.